Top-Rated StocksTop-RatedNASDAQ:KRRO Korro Bio (KRRO) Stock Price, News & Analysis $12.18 -0.01 (-0.08%) Closing price 11/20/2026 04:00 PM EasternExtended Trading$12.00 -0.18 (-1.49%) As of 11/20/2026 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Korro Bio Stock (NASDAQ:KRRO) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Korro Bio alerts:Sign Up Key Stats Today's Range$12.01▼$12.9550-Day Range$8.49▼$16.6252-Week Range$5.20▼$17.35Volume123,521 shsAverage Volume205,959 shsMarket Capitalization$167.23 millionP/E RatioN/ADividend YieldN/APrice Target$17.29Consensus RatingBuy Company Overview Korro Bio is a clinical-stage biotechnology company headquartered in Cambridge, Massachusetts. It develops RNA-editing medicines intended to address genetic diseases by changing specific RNA sequences rather than altering a patient’s DNA. The company’s OPERA platform uses oligonucleotides to direct the body’s naturally occurring ADAR enzymes to edit targeted RNA. Korro has developed KRRO-110, an investigational candidate designed to correct a disease-associated RNA change linked to alpha-1 antitrypsin deficiency. The candidate is not an approved treatment. Korro’s work is focused on developing and evaluating its therapies, rather than marketing an established portfolio of commercial products. Its research and clinical development activities are based in the United States.AI Generated. May Contain Errors. Read More Korro Bio Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks54th Percentile Overall ScoreKRRO MarketRank™: 2.67827181208 of 5 starsKorro Bio scored higher than 54% of companies evaluated by MarketBeat, and ranked 437th out of 845 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion4.0 / 5Analyst RatingBuy Consensus RatingKorro Bio has received a consensus rating of Buy. The company's average rating score is 3.10, and is based on 3 strong buy ratings, 6 buy ratings, no hold ratings, and 1 sell rating.Upside PotentialKorro Bio has a consensus price target of $17.29, representing about 41.9% upside from its current price of $12.18.Amount of Analyst CoverageKorro Bio has only been the subject of 2 research reports in the past 90 days.Read more about Korro Bio's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthGrowing Earnings GrowthEarnings for Korro Bio are expected to grow in the coming year, from ($4.45) to ($4.41) per share.Price to Book Value per Share RatioKorro Bio has a P/B Ratio of 1.89. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Short Interest1.0 / 5Short Interest LevelBearish Percentage of Shares Shorted12.48% of the float of Korro Bio has been sold short.Short Interest Ratio / Days to CoverKorro Bio has a short interest ratio ("days to cover") of 8.18.Change versus previous monthShort interest in Korro Bio has recently increased by 0.94%, indicating that investor sentiment is decreasing. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldKorro Bio does not currently pay a dividend.Dividend GrowthKorro Bio does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.90 News SentimentKorro Bio has a news sentiment score of 0.90. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.41 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Korro Bio this week, compared to 3 articles on an average week.Search Interest2 people have searched for KRRO on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership1.8 / 5Insider TradingSelling Shares Insider Buying vs. Insider SellingIn the past three months, Korro Bio insiders have sold 21.73% more of their company's stock than they have bought. Specifically, they have bought $884,919.00 in company stock and sold $1,077,172.00 in company stock.Percentage Held by Insiders4.80% of the stock of Korro Bio is held by insiders.Percentage Held by Institutions13.18% of the stock of Korro Bio is held by institutions.Read more about Korro Bio's insider trading history. Receive KRRO Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Korro Bio and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. KRRO Stock News HeadlinesKorro to Participate in Upcoming Investor ConferencesNovember 19 at 7:00 AM | globenewswire.comKorro Bio (NASDAQ:KRRO) Director Sells 26,587 Shares of Company StockNovember 15, 2026 | insidertrades.comYour book is insideThe "Sucker's Bet" Most New Options Traders Fall For Most people who try options lose money the same way. They don't know the rules. They don't know what to avoid. And they hand their account to Wall Street on a silver platter. Normally $29.97. Free today.November 21 at 1:00 AM | Profits Run (Ad)Korro Bio Insider Sold Shares Worth $973,609, According to a Recent SEC FilingNovember 14, 2026 | marketscreener.comMKorro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)November 13, 2026 | globenewswire.comKorro Bio Stock Gets Higher EPS Estimate from HC WainwrightNovember 12, 2026 | americanbankingnews.comKorro Bio, Inc. (NASDAQ:KRRO) Stock Now Rated "Moderate Buy" by Sell-Side BrokeragesNovember 10, 2026 | americanbankingnews.comKorro Bio (NASDAQ:KRRO) Major Shareholder Purchases 2,510 Shares of Company StockOctober 27, 2026 | insidertrades.comSee More Headlines KRRO Stock Analysis - Frequently Asked Questions How have KRRO shares performed this year? Korro Bio's stock was trading at $8.01 on January 1st, 2026. Since then, KRRO stock has increased by 52.1% and is now trading at $12.18. How were Korro Bio's earnings last quarter? Korro Bio, Inc. (NASDAQ:KRRO) announced its quarterly earnings data on Thursday, November, 5th. The company reported ($0.98) earnings per share for the quarter, topping the consensus estimate of ($1.14) by $0.16. When did Korro Bio IPO? Korro Bio (KRRO) raised $90 million in an initial public offering on Thursday, October 3rd 2019. The company issued 6,000,000 shares at $14.00-$16.00 per share. Who are Korro Bio's major shareholders? Korro Bio's top institutional shareholders include Nantahala Capital Management LLC (4.95%), State Street Corp (1.78%), Goldman Sachs Group Inc. (0.78%) and North Star Investment Management Corp.. Insiders that own company stock include Lynx1 Capital Management Lp, Paul Edward Walker, Enterprise Associates 17 New, Anthony A Jr Florence, Mohamad Makhzoumi, Rick Yang, Venture Opportunity Fund Atlas, Jean Francois Formela, Ram Aiyar, David L Lucchino, Loic A Vincent, Todd Chappell, Oliver Dolan and Vineet Agarwal. View institutional ownership trends. How do I buy shares of Korro Bio? Shares of KRRO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Company Calendar Last Earnings11/05/2026Today11/21/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (10m+) 1-Year History Nov 25 Feb 26 May 26 Aug 26 Nov 26 KRRO's financial health is in the Green zone, according to TradeSmith. KRRO has been in this zone for over 10 months. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Biotechnology Sub-IndustryBiotechnology Current SymbolNASDAQ:KRRO Previous SymbolNASDAQ:KRRO CIK1703647 Webwww.korrobio.com Phone781-315-4600FaxN/AEmployees57Year Founded2018Price Target and Rating Average Price Target for Korro Bio$17.29 High Price Target$23.00 Low Price Target$10.00 Potential Upside/Downside+41.9%Consensus RatingBuy Rating Score (0-4)3.10 Research Coverage10 Analysts Profitability EPS (Trailing Twelve Months)($9.06) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$117.26 million Net MarginsN/A Pretax Margin-8,129.41% Return on Equity-117.06% Return on Assets-69.74% Debt Debt-to-Equity RatioN/A Current Ratio7.30 Quick Ratio7.30 Sales & Book Value Annual Sales$6.39 million Price / Sales26.17 Cash FlowN/A Price / Cash FlowN/A Book Value$6.44 per share Price / Book1.89Miscellaneous Outstanding Shares13,730,000Free Float13,067,000Market Cap$167.23 million OptionableOptionable Beta3.23 Social Links Don't Wait for the OpenAI IPOThe AI wave will soon hit public markets with Anthropic and OpenAI set to go public later this year. However, you don't have to wait to invest. This report shows seven AI stocks that you can buy today while the big model providers get ready to go public.Get This Free Report This page (NASDAQ:KRRO) was last updated on 11/20/2026 by MarketBeat.com Staff. From Our PartnersTop Trader Reveals Stunning Black Friday DealOthers paid $500 for the Snapback Indicator. This Black Friday, it's available for just $7. Base Camp Tradi...Base Camp Trading | SponsoredToday's free pick (on me)Elon Musk doesn't own the chip inside every Tesla, Starlink dish, and AI satellite - he licenses it from one l...Behind the Markets | SponsoredYour free book is about to disappearBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time throug...Profits Run | Sponsored432 miles southeast of Washington, DC…Spruce Pine, North Carolina, a town of just over 2,000 people, has supplied a material to every major chip mak...Wall Street Watchdogs | SponsoredBeyond NVDA: The World’s Next #1 Company?This small-cap trades in an overlooked corner of the market, with a market cap more than 600X smaller than Nvi...Banyan Hill Publishing | SponsoredCFA: Bank of America Said THISOn January 24th, 2022, Bank of America told Bloomberg something that should terrify every American with a savi...Decentralized Masters | SponsoredMy public warning after 55 years of watching the marketsDr. Martin D. Weiss has publicly predicted six major American market crashes over his 55-year career, each war...Weiss Ratings | SponsoredThe investigation Porter spent tens of thousands to documentPorter Stansberry flew the Porter and Co. team 3,300 miles to Dublin to investigate a 17-year investing experi...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Korro Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Korro Bio With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.